GK Activator (2)
Sponsors
Hoffmann-La Roche
Conditions
Diabetes Mellitus Type 2Diabetes Mellitus, Type 2
Phase 1
A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes.
CompletedNCT00368368
Start: 2006-01-31End: 2007-08-31Updated: 2016-11-02
A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.
CompletedNCT00377442
Start: 2006-08-31End: 2007-04-30Updated: 2016-11-02
A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.
CompletedNCT00388986
Start: 2006-10-31End: 2007-07-31Updated: 2016-11-02
A Study of the Pharmacokinetics/Pharmacodynamics of GK Activator (2) in Type 2 Diabetes Patients With Hepatic Impairment.
TerminatedNCT00437606
Start: 2007-03-31End: 2007-06-30Updated: 2016-08-24
Phase 2
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
CompletedNCT00266240
Start: 2005-11-30End: 2007-05-31Updated: 2016-11-02
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
CompletedNCT00266253
Start: 2005-11-30End: 2007-03-31Updated: 2016-11-02
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
CompletedNCT00316758
Start: 2006-02-28End: 2007-10-31Updated: 2016-11-02
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
CompletedNCT00366379
Start: 2006-07-31End: 2007-06-30Updated: 2016-11-02